In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Dr. Reddy’s To Focus On Providing Niche Services

This article was originally published in PharmAsia News

Executive Summary

Dr. Reddy's Laboratories of India plans to change the way it does business, focusing on niche services to gain an edge in the highly competitive generic drugs business. As a lead-up to the new emphasis, the company has combined its custom pharmaceutical services with its division for active pharmaceutical ingredients. The new division is called Pharmaceutical Services and Active Ingredients. A senior vice president at Dr. Reddy's, Abhijit Mukerjee, is to head the new division, and says the move is intended to take advantage of "a huge wealth of expertise." His division plans to provide research and manufacturing services matched to its clients, many of the services involving chemical molecules. (Click here for more



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts